What if you could control computers with just a thought? Precision Neuroscience is one of several companies working to make that a reality. Michael Mager is the co-founder and CEO of the brain-computer interface company whose technology aims to give patients with severe mobility issues new ways to interact with the digital world. How does Precision plan to offer brain implants to millions of people who could benefit from them? And how is the company competing with rivals like Synchron and Elon Musk’s Neuralink? Mager speaks to WSJ’s Christopher Mims and Tim Higgins on the latest episode of the Bold Names podcast.